Ingevity Corporation $NGVT Shares Sold by Wellington Management Group LLP

Key Points

• Wellington Management cut its Ingevity stake by 28% in the second quarter, selling 418,778 shares and retaining 1.08 million shares worth approximately $80.3 million. Institutional investors collectively own 91.59% of the company.
• Ingevity exceeded quarterly earnings expectations, reporting $1.74 in EPS versus the $1.33 consensus and revenue of $314.1 million. The company set full-year 2026 EPS guidance at $5.00–$5.45.
• Company insiders sold 17,801 shares worth about $1.35 million over the past 90 days, while analysts maintain an average “Hold” rating and an $80 price target; shares recently opened at $69.03.

Wellington Management Group LLP reduced its position in Ingevity Corporation (NYSE:NGVT - Free Report) by 28.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,075,514 shares of the company's stock after selling 418,778 shares during the quarter. Wellington Management Group LLP owned approximately 3.13% of Ingevity worth $80,309,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Empowered Funds LLC bought a new position in Ingevity during the 2nd quarter worth approximately $307,000. Public Employees Retirement System of Ohio bought a new stake in shares of Ingevity in the 2nd quarter valued at approximately $75,000. Corient Private Wealth LP acquired a new stake in shares of Ingevity during the 2nd quarter valued at approximately $488,000. Bank of America Corp DE acquired a new stake in shares of Ingevity during the 2nd quarter valued at approximately $23,628,000. Finally, Freestone Grove Partners LP bought a new position in Ingevity during the second quarter worth $152,000. Institutional investors and hedge funds own 91.59% of the company's stock.

Insiders Place Their Bets

In other Ingevity news, SVP Ryan C. Fisher sold 2,709 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the sale, the senior vice president directly owned 15,722 shares of the company's stock, valued at $1,159,025.84. This trade represents a 14.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO David H. Li sold 5,000 shares of the firm's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the sale, the chief executive officer owned 120,636 shares in the company, valued at $9,147,827.88. The trade was a 3.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 17,801 shares of company stock valued at $1,347,481. 0.88% of the stock is owned by company insiders.

Ingevity Stock Performance

Shares of NGVT stock opened at $69.03 on Thursday. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. The business has a 50 day moving average of $73.27 and a two-hundred day moving average of $71.67. Ingevity Corporation has a 52 week low of $45.85 and a 52 week high of $79.29. The company has a market cap of $2.37 billion, a P/E ratio of 46.96 and a beta of 1.17.

Ingevity (NYSE:NGVT - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping analysts' consensus estimates of $1.33 by $0.41. The business had revenue of $314.10 million for the quarter, compared to analysts' expectations of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, analysts anticipate that Ingevity Corporation will post 5.4 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have commented on NGVT. Wall Street Zen downgraded shares of Ingevity from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 1st. Weiss Ratings raised shares of Ingevity from a "sell (d-)" rating to a "hold (c-)" rating in a report on Friday, July 31st. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Ingevity has an average rating of "Hold" and an average price target of $80.00.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.